Foundation year: 1997

NACE classifier: 21.10; 20.42

Valid certificates:

Authorization for wholesale distribution of medical products for human use, Authorization for active pharmaceutical ingredients manufacturing.

Ltd "Larifans" produces medical products and cosmetics, based on the original pharmaceutical active substance dsRNA Larifan. The original active substance is developed at the 1976, commercial production is being performed since 1994.
Larifan is an immunomodulator, interferon inducer of natural origin with a broad spectrum of action. Larifan is used in fields such as immunology, virology, oncology, etc. Larifan widely is used for the correction of the immune system at different viral disease mainly: herpes virus, influenza, encephalitis, hepatitis, papillomas (warts) and different sexually transmissible disease.

Main markets

  1. 1. Belarus
  2. 2. Georgia
  3. 3. Estonia
  4. 4. Lithuania

Target Markets

  1. 1. Malaysia
  2. 2. Uzbekistan

In which areas are looking for cooperation

  • Manufacturing of active pharmaceutical ingredients and pharmaceuticals

Products

Ointment - Larifan Ungo

LARIFAN UNGO is a remedy for skin and mucosa care. The ointment includes a patented natural origin component dsRNA LARIFAN which provides ointments additional value. dsRNA Larifan increases body’s local resistance to adverse environmental factors, including protection of the body against viral penetration.

Lip balm LARIFAN

Lip balm LARIFAN is created for lips and mucous membrane care and protection. Lip balm LARIFAN is an efficient remedy for body’s natural resistance regulation, thus protecting against harmful external environmental factors (including viruses, bacteria).

Showing similar companies

By the industry in which it operates

Foundation year: 1997

NACE classifier: 21.10; 20.42

Turnover in the last 5 years

Data are not able

Data are not able

Empty chart placeholder

Number of employees in total and after education in the last 5 years

Data are not able

Data are not able

Empty chart placeholder

In which areas are looking for cooperation

  • Manufacturing of active pharmaceutical ingredients and pharmaceuticals

Export volume over the last 5 years

Thousands EUR

Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2016 to 2020.

2016 2017 2018 2019 2020
82215 88935 n/a n/a n/a

Main markets

  1. 1. Belarus
  2. 2. Georgia
  3. 3. Estonia
  4. 4. Lithuania

Target Markets

  1. 1. Malaysia
  2. 2. Uzbekistan

Investing in R&D

Data are not able

Data are not able

Empty chart placeholder

Larifāns SIA

Description about enterprise:

Ltd "Larifans" produces medical products and cosmetics, based on the original pharmaceutical active substance dsRNA Larifan. The original active substance is developed at the 1976, commercial production is being performed since 1994.
Larifan is an immunomodulator, interferon inducer of natural origin with a broad spectrum of action. Larifan is used in fields such as immunology, virology, oncology, etc. Larifan widely is used for the correction of the immune system at different viral disease mainly: herpes virus, influenza, encephalitis, hepatitis, papillomas (warts) and different sexually transmissible disease.

Valid certificates:

Authorization for wholesale distribution of medical products for human use, Authorization for active pharmaceutical ingredients manufacturing.

Products

Ointment - Larifan Ungo

LARIFAN UNGO is a remedy for skin and mucosa care. The ointment includes a patented natural origin component dsRNA LARIFAN which provides ointments additional value. dsRNA Larifan increases body’s local resistance to adverse environmental factors, including protection of the body against viral penetration.

Lip balm LARIFAN

Lip balm LARIFAN is created for lips and mucous membrane care and protection. Lip balm LARIFAN is an efficient remedy for body’s natural resistance regulation, thus protecting against harmful external environmental factors (including viruses, bacteria).